This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

John Gill IV
Director, Cell Line Development at Samsung Biologics


A graduate of the University of New Hampshire, John is a 24 year biotech veteran in Cell Line Development with expertise in monoclonality and single cell isolation. He also has experience ranging from cell banking and upstream process development to Discovery efforts as a Pre-Clinical Program Lead in both large pharma and CDO/CMOs.

Agenda Sessions

  • Accelerated High Performance Cell Line Development at SBL